Table 2 Baseline characteristics of the participants
Study | Study arms | N. of patients in each group | Male, N.% | Ischemic etiology, N.% | Age (Years), Mean (SD) | BMI, Mean (SD) | SBP, Mean (SD) | DBP, Mean (SD) | HR, Mean (SD) | ALI, Mean (SD) | Left atrial diameter, mm | LVEF, Mean (SD) | Laboratory data, Mean (SD) | Comorbidities N. (%) | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
AST, U/L | ALT, U/L | Creatinie (mg/dl) | Hgb (g/dl) | CRP, (mg/dl) | Chloride (mmol/L) | Potassium (mmol/L) | Sodium (mmol/L) | NLR (mmol/L) | Albumin, g/dl | HTN | DM | |||||||||||||
Kurkiewicz et al. 2023 [25] | All population | 200 | 179 (89.5) | 118 (59) | 57.8 (9.3) | 27.1 (4.7) | NA | NA | NA | 40.4 (20.4) | 52.3 (8.2) | 17.3 (3.7) | 26 (9) | 23.3 (13.4) | 1.24 (0.26) | 14.18 (1.45) | NA | NA | NA | 139 (3) | NA | 4.3 (0.4) | 114 (57) | 81 (40.5) |
Maeda et al. 2020 [19] | ALI < 23.88 | 127 | 79 (63) | 51 (40.2) | 75.3 (8.9) | 21.4 (4) | 135.6 (35) | 78.6 (17.2) | NA | 15.9 (6.1) | 48.3 (8.2) | 43.3 (17) | 23.3 (10.4) | 15.3 (8.2) | 1.46 (0.89) | 10.8 (2.2) | 0.68 (0.832) | 101 (4.5) | 4.3 (0.52) | 138.7 (3.7) | 4.1 (1.7) | 3.1 (4) | 90 (70.9) | 49 (38.6) |
23.88 ≤ ALI < 42.43 | 127 | 79 (63) | 37 (29.1) | 75.6 (9.7) | 23.8 (3.7) | 133.3 (27.7) | 79 (19.5) | NA | 32.7 (7) | 49.3 (8.2) | 49.7 (21) | 23.3 (10.5) | 17.3 (9) | 1.1 (0.43) | 12 (1.7) | 0.21 (0.27) | 101.6 (3.7) | 4.3 (0.4) | 139.7 (3.7) | 2.3 (0.52) | 3.5 (0.4) | 93 (73.3) | 41 (32.2) | |
ALI ≥ 42.43 | 127 | 67 (52.8) | 31 (24.4) | 72.6 (10.5) | 24.4 (4.8) | 138 (32.2) | 80.3 (18.75) | NA | 59.4 (17.9) | 50.3 (8.2) | 45 (18.7) | 25.6 (10.5) | 22 (17.24) | 1.08 (0.36) | 12.66 (2.5) | 0.18 (0.19) | 101.7 (3.7) | 4.5 (0.45) | 140 (3) | 1.4 (0.52) | 3.6 (0.45) | 92 (72.4) | 40 (31.5) | |
Shi et al. 2023 [18] | ALI < 24.60 | 561 | 359 (64) | NA | 69.6 (11.5) | 22.26 (3.39) | 121.135 (22.83) | 74.91 (14.719) | 87.01 (21.83) | NA | 41.38 (9.55) | 45.94 (18.1) | 33.50 (21.9) | 28.59 (20.41) | 1.3 (0.53) | 13.46 (2.44) | 1.8 (2.2) | 102.13 (5) | 3.92 (0.64) | 140.28 (4.84) | 5.94 (3.05) | 3.54 (0.47) | 320 (57) | 169 (30.1) |
ALI ≥ 24.60 | 562 | 334 (59.4) | NA | 64.2 (13) | 23.657 (4.14) | 122.619 (22.82) | 77.56 (15.24) | 83.899 (20.38) | NA | 43.41 (9.23) | 43.30 (18.1) | 28.81 (14.7) | 28.44 (19.42) | 1.14 (0.43) | 14.18 (2.28) | 0.71 (0.8) | 103.66 (4.22) | 3.95 (0.54) | 141.78 (3.94) | 2.23 (0.78) | 3.79 (0.39) | 300 (53.38) | 146 (26) | |
Sun et al. 2024 [26] | ALI < 7.1 | 181 | 114 (62.3) | NA | 73.7 (15.7) | 26.8 (5.9) | 111.3 (15.5) | 61.3 (10.5) | 85.7 (18.1) | 3.9 (2.2) | NA | NA | 100.8 (131.2) | 61.5 (75.1) | 1.7 (1.05) | 10.6 (2.4) | NA | NA | 4.8 (0.8) | 140.3 (4.5) | 23.7 (11.4) | 3.2 (0.6) | 68 (37.2) | 71 (38.8) |
ALI 7.1–15.2 | 183 | 107 (57.5) | NA | 72.7 (13.7) | 29.2 (6.9) | 112.5 (14.3) | 61.7 (10.8) | 85.7 (19) | 10.6 (3) | NA | NA | 105 (154) | 56.7 (71.7) | 1.9 (1.4) | 10.6 (2.9) | NA | NA | 4.6 (0.8) | 140 (4.5) | 9.3 (3.2) | 3.4 (0.5) | 84 (45.2) | 74 (39.8) | |
ALI ≥ 15.2 | 184 | 108 (60.3) | NA | 70.1 (15.9) | 30.4 (7.3) | 112.9 (16) | 62.8 (9.7) | 84.4 (16.5) | 24.7 (10.7) | NA | NA | 54.7 (53.5) | 36.6 (36.5) | 1.5 (1) | 10.7 (2.8) | NA | NA | 4.6 (0.7) | 140.1 (4.3) | 4.4 (1.9) | 3.5 (0.5) | 76 (42.5) | 84 (46.9) | |
Yuan et al. 2022 [20] | ALI < 25.8 | 372 | 188 (50.5) | 205 (55.1) | 77 (7.44) | 22.15 (3.42) | 134.75 (27.54) | 75.70 (14.88) | 89.40 (22.33) | 13.78 (7.96) | NA | 52.25 (14.1) | 28.75 (14.1) | 23.4 (14.88) | 1.14 (0.52) | 12.13 (1.94) | NA | NA | 4.13(0.89) | 138.65 (3.72) | 6.56 (3.20) | 3.76 (0.52) | 243 (65.3) | 115 (31) |
ALI ≥ 25.8 | 171 | 59 (35.5) | 90 (52.6) | 75.35 (8.22) | 24.47 (4.34) | 133 (19.43) | 75.76 (14.21) | 83.05 (17.19) | 38.95 (13.31) | NA | 55.54 (12.7) | 24.35 (9.72) | 21.26 (13.46) | 0.94 (0.37) | 12.56 (1.57) | NA | NA | 4.1(.45) | 140.70 (2.99) | 2.6 (0.89) | 4 (0.45) | 114 (66.7) | 4 3(25) | |